Emily Brooks is an endocrinologist and clinician-researcher at the Princess Alexandra Hospital (PAH) and a senior lecturer and principal specialty supervisor (medicine) at the Princess Alexandra-Southside Clinical Unit, University of Queensland School of Medicine, Faculty of Medicine. She earned her Bachelor of Pharmacy (Honours Class I), Bachelor of Medicine, Bachelor of Surgery, and Medical Science from The University of Queensland. After completing physician training in Queensland, she undertook a fellowship in pituitary medicine at St Vincent’s Hospital and the Garvan Institute of Medical Research in Sydney, earning Fellowship of the Royal Australasian College of Physicians (FRACP) in 2021. Brooks was conferred a PhD by The University of Queensland in 2021 for her part-time thesis titled “Individualisation of immunosuppression in adult kidney transplant recipients,” later published as “Evaluating prediction methods for estimating tacrolimus, mycophenolate and prednisolone exposure following adult kidney transplantation.” Her clinical practice at PAH includes inpatient and outpatient management of general endocrinology, bone and thyroid conditions, diabetes mellitus, with a sub-specialty interest in pituitary conditions as the pituitary co-lead for the PAH Diabetes and Endocrinology Department.

Brooks is an emerging leader in endocrinology research, evidenced by her growing track record of publications in high-impact peer-reviewed journals. Notable works include “Approach to the patient – disorders of salt and water balance post pituitary surgery” (The Journal of Clinical Endocrinology and Metabolism, 2023), “Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals” (Clinical Endocrinology, 2021), “Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients” (Therapeutic Drug Monitoring, 2020), “Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients” (Therapeutic Drug Monitoring, 2019), and “Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients” (Therapeutic Drug Monitoring, 2018). Her research specializations include pituitary conditions such as hypothalamic-pituitary-adrenal axis disorders, posterior pituitary conditions, and pituitary tumours, as well as osteoporosis. Current research is funded by a Queensland Health Clinical Research Fellowship, Endocrine Society of Australia Post-Doctoral Fellowship, RACP-ESA Research Establishment Fellowship, and two MetroSouth Research Support Scheme grants. She mentors research higher degree candidates, junior medical doctors on research projects, and physician trainees in specialty training.

Professional Email: e.brooks@uq.edu.au